In addition, the protein CDR1, an APCCDH1 substrate, binds c-MYC to activate its transactivation; elevated accumulation of CDR1 in cancer cells as a result of APC inhibition or defect promotes c-MYC oncogenic function [80]. This evidence concerns the gene MYC and cancer.